234 related articles for article (PubMed ID: 28698192)
1. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
Mortensen MB; Falk E; Schmidt M
Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698192
[No Abstract] [Full Text] [Related]
2. National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey.
Salami JA; Warraich HJ; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Katzen BT; Lloyd-Jones D; Krumholz HM; Nasir K
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358195
[TBL] [Abstract][Full Text] [Related]
3. Pattern of statins' utilization at Ramathobodi Hospital, 2005 to 2007.
Pattanaprateep O; Pongcharoensuk P; Suvanakoot P; Kaojarern S
J Med Assoc Thai; 2010 Oct; 93(10):1223-31. PubMed ID: 20973328
[TBL] [Abstract][Full Text] [Related]
4. Rising prescription drug costs: whose responsibility?
Hill SR; Henry DD; Smith AJ
Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
[No Abstract] [Full Text] [Related]
5. Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide.
Hopkins AM; Vitry AI; O'Doherty CE; Proudman SM; Wiese MD
Int J Rheum Dis; 2017 Nov; 20(11):1795-1797. PubMed ID: 26176865
[No Abstract] [Full Text] [Related]
6. Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017.
Rome BN; Lee CC; Gagne JJ; Kesselheim AS
Value Health; 2021 Jun; 24(6):804-811. PubMed ID: 34119078
[TBL] [Abstract][Full Text] [Related]
7. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017.
Maly J; Dvorackova S; Zimcikova E; Kubena AA; Kolar J; Vlcek J; Penka M; Mala-Ladova K
J Thromb Thrombolysis; 2019 Feb; 47(2):305-311. PubMed ID: 30659407
[TBL] [Abstract][Full Text] [Related]
8. Trends in antidiabetic drug utilization and expenditure in Denmark: A 22-year nationwide study.
Bang C; Mortensen MB; Lauridsen KG; Bruun JM
Diabetes Obes Metab; 2020 Feb; 22(2):167-172. PubMed ID: 31486269
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic medications use trends in an Andalusian region from 2001 to 2014.
López-Sepúlveda R; García Lirola MÁ; Espínola García E; Jurado Martínez JM; Martín Sances S; Anaya Ordóñez S; Cabeza Barrera J
Prim Care Diabetes; 2017 Jun; 11(3):254-264. PubMed ID: 28126469
[TBL] [Abstract][Full Text] [Related]
10. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
[TBL] [Abstract][Full Text] [Related]
11. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
Siegel D; Lopez J; Meier J
Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
[No Abstract] [Full Text] [Related]
12. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
13. Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
Warraich HJ; Salami JA; Khera R; Valero-Elizondo J; Okunrintemi V; Nasir K
JAMA Intern Med; 2018 May; 178(5):719-721. PubMed ID: 29525818
[TBL] [Abstract][Full Text] [Related]
14. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
Kamata Y; Minota S
Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
[TBL] [Abstract][Full Text] [Related]
15. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
16. Trend of cost and utilization of COPD medication in Korea.
Lee J; Lee JH; Kim JA; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2017; 12():27-33. PubMed ID: 28031708
[TBL] [Abstract][Full Text] [Related]
17. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
[TBL] [Abstract][Full Text] [Related]
18. Prescribing efficiency of proton pump inhibitors in China: influence and future directions.
Zeng W; Finlayson AE; Shankar S; de Bruyn W; Godman B
BMC Health Serv Res; 2015 Jan; 15():11. PubMed ID: 25609265
[TBL] [Abstract][Full Text] [Related]
19. Resistance to in-office dispensing of generic antibiotic samples.
Kogut SJ; Spooner LM
J Manag Care Pharm; 2009; 15(1):62-5. PubMed ID: 19125551
[No Abstract] [Full Text] [Related]
20. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
